Turning Tarantula Venom into Pain Relief | UC Davis Health Research
Автор: UC Davis Health
Загружено: 2021-07-13
Просмотров: 4485
Описание:
Researchers at UC Davis are developing a new type of pain medication from an unusual source — tarantula venom. The project is part of the NIH initiative Helping to End Addiction Long-Term (HEAL Initiative), aimed at ending opioid addiction and creating non-addictive therapies to treat pain. Vladimir Yarov-Yarovoy, a professor of physiology and membrane biology, and Heike Wulff, a professor of pharmacology, are leading the 20-person team using computational biology to turn a poisonous peptide into one that can relieve pain. Peptides are smaller versions of proteins. Tarantulas were filmed at the Bohart Museum of Entomology, located on the UC Davis campus.
Learn more about this study: https://health.ucdavis.edu/health-new...
——
UC Davis Health is committed to improving health for all through collaborative clinical, translational and basic science research. Across our organization, innovative studies are driving new technologies, treatments and therapies that directly benefit patients. With more clinical trials than any other health care provider in our region and renowned research centers led by internationally recognized experts, UC Davis Health is driving discoveries that address today’s most pressing health challenges.
Driving Discovery at UC Davis Health: • Driving Discovery - Research Studies and C...
Research at UC Davis Health: https://health.ucdavis.edu/research/
Clinical trials at UC Davis Health: https://studypages.com/ucdavis/home/
UC Davis School of Medicine: https://medschool.ucdavis.edu
See the latest news from UC Davis Health: https://health.ucdavis.edu/newsroom
——
The information in this video was accurate as of the upload date, 7/13/21. For information purposes only. Consult your local medical authority for advice.
#opioidepidemic #tarantula #research #painrelief #ucdavis
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: